期刊文献+

HDAC2-反义脱氧寡核苷酸抑制Ang Ⅱ诱导的心肌细胞肥大

Inhibitory effect of histone deacetylase 2-antisense oligonucleotide on cardiocyte hypertrophy induced by angiotensin Ⅱ
下载PDF
导出
摘要 目的:利用反义脱氧寡核苷酸技术探讨组蛋白脱乙酰基酶2(HDAC2)对心肌细胞肥大的促进作用,为探寻心肌细胞肥大的发病机理及其防治提供一新的思路。方法:常规方法培养原代心肌细胞,利用血管紧张素Ⅱ(AngⅡ)刺激心肌细胞制成心肌细胞肥大的体外模型,应用Fugene 6转染HDAC2-反义脱氧寡核苷酸进行干预。以逆转录聚合酶链反应(RT-PCR)观察HDAC2和β肌球蛋白重链(β-MHC)mRNA的表达;通过相差显微镜观察心肌细胞的形态和面积;利用免疫组织化学法检测心肌细胞HDAC2和c-fos蛋白的表达。结果:与对照组相比,肥大组心肌细胞面积,HDAC2 mRNA和β-MHC mRNA表达均增加(P均<0.01);HDAC2蛋白和c-fos蛋白表达增加(P<0.01)。利用Fugene 6将HDAC2-反义脱氧寡核苷酸转染入心肌细胞,HDAC2-反义脱氧寡核苷酸组心肌细胞面积较肥大组减小,HDAC2 mRNA和β-MHC mRNA表达减少,HDAC2蛋白表达亦减少(P均<0.05)。Fugene 6组,错义组与肥大组变化相似。结论:AngⅡ致心肌细胞肥大过程中伴有HDAC2的mRNA和蛋白表达增加,应用HDAC2反义脱氧寡核苷酸后可使之下降,说明HDAC2参与了心肌细胞的肥大机制。 Objective: To observe the inhibitory effect of histone deacetylase 2--antisense oligonucleotide on cardiocyte hypertrophy induced by angiotensin Ⅱ. Methods: The cultured cardiocytes divided into control group, Fugene group (treated with Ang Ⅱ and Fugene), cardiocyte hypertrophy group (treated with Ang Ⅱ to induce hypertrophy), HDAC2--ASODN group [given with histone deacetylase 2 (HDAC2) --antisense oligonucleotide (ASODN) and Ang Ⅱ] and HDAC2--missence oligonucleotide (MSODN) group (given with HDAC2, MSODN and Ang Ⅱ). The morphologic changes of cardiocytes were observed under the contrast phase microscope. The mRNA levels of HDAC2 and β-MHC were examined by real-time PCR method. The protein expressions of HDAC2 and c-fos, was examined by immunohistochemistry method. Results: Compared with control group, the cardiocytes enlarged (P〈0.01) under the contrast phase microscope; the mRNA levels of HDAC2 and β-MHC and the protein expressions of HDAC2 and C-los increased (P〈0.01) in hypertrophic cardiocytes; but given by HDAC2--ASODN, these indexes decreased (P〈0.05). There was no significant difference among Fugene 6 group and cardiocyte hypertrophy group and HDAC2-- MSODN group. Conclusion: The results means that HDAC2 may play a role in genesis of cardiocyte hypertrophy. HDAC2 ASODN may be a new drug to treat cardiocyte hypertrophy.
出处 《心血管康复医学杂志》 CAS 2009年第1期13-16,22,共5页 Chinese Journal of Cardiovascular Rehabilitation Medicine
基金 黑龙江省教育厅课题(11511208)
关键词 组蛋白脱乙酰基酶类 血管紧张素Ⅱ 心肌 Histone deacetylases Angiotensin Ⅱ Myocardium
  • 相关文献

参考文献9

  • 1Antos CL, McKinsey TA, Dreitz M, et al. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors [J]. J BiolChem, 2003, 278 (31): 28930--28937. 被引量:1
  • 2Kee HJ, Sohn JS, Nam KI, et al. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin Ⅱ infusion and aortic banding[j]. Circulation, 2006 113 (1) : 51 -- 59. 被引量:1
  • 3汤屹,刘文励,周剑锋.组蛋白去乙酰化酶抑制剂治疗肿瘤的机制和临床应用研究进展[J].中华血液学杂志,2002,23(6):329-331. 被引量:19
  • 4Zhang CL, McKinsey TA, Chang S, et al. Class Ⅱ histone deacetylases act as signal-responsive repressors of cardiac hypertrophy [J]. Cell, 2002, 110 (4)= 479--488. 被引量:1
  • 5Starksen NF, Simpson PC, Bishopric N, et al. Cardiac myocyte hy pertrophy is associated with c-myc protooncogene exprcssion[J] Proc Natl Acad Sci USA, 1986,83(21 ) :8348--8350. 被引量:1
  • 6Zeng Y, Tang CM, Yao YL, et al. Cloning and characterization of the mouse histone deaeetylase--2 gene [JJ. J Biol Chem, 1998, 273 (44): 28921--28930. 被引量:1
  • 7Tsai SC, Seto E. Regulation of histone deacetylase 2 by protein kinase CK2[J]. J Biol Chem,2002,277(35) :31826--31833. 被引量:1
  • 8Galasinski SC, Resing KA, Goodrich JA, et al. Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions [J]. J Biol Chem, 2002, 277 (22):19618--19626. 被引量:1
  • 9唐琳,张云汉.反义核酸技术与肿瘤研究[J].河南大学学报(医学版),2005,24(2):24-27. 被引量:1

二级参考文献33

  • 1Woolf TM, Jennings CG, Rebagliati M,et al. The stability, toxicity and effectiveness of unmodified and phosphorothioate antisense oligodeoxynucleotides in Xenopus oocytes and embryos[J]. Nucleic Acids Res, 1990,18(7):1763-1769. 被引量:1
  • 2Caruthers MH. oligodeoxynucleotides as Therapeutic Agents[J].Ciba Found Symp,1997,209:1-4. 被引量:1
  • 3Galderisi U, Cascino A, Giordano A. Antisense oligodeoxynucleotides as therapeutic agents[J].Cell Physiol,1999,181(2):251-257. 被引量:1
  • 4Iribanen AM, Spmat BS, Neuner P, et at. 2'-O alkyl otigonbonucleotides as antisense probes. Probes. Proc Natl Acad Sci USA, 1990,87(19):7747-7751. 被引量:1
  • 5Hudziak RM, Banofsky E, Barofsky DF, et al. Resistance of morpholino phosphorodiamidate oligoners to enzymatic degradation. Antisense Nucleic Acid Drug Dev, 1996,6(4):267-272. 被引量:1
  • 6McCarthy MM, Auger AP, Mong JA, et al. Antisense oligodeoxynuclectides as a tool in developmental neuroendocrinology. Methods.2000,22(3):239-248. 被引量:1
  • 7Schmajuk G, Sierakowska H, Kole R. Antisense digonucleotides with different backbooes. Modification of splicing pathways and efficacy of uptake. J Bid Chem, 1999,274(31):21783-21789. 被引量:1
  • 8Gutierrez Puente Y, Zapata Benavides P, Tari AM, et al. Bcl-2 -related antisense therapy [J]. Semin Oncol, 2002,29(3Suppl 11):71-76. 被引量:1
  • 9Nita ME, Ono- Nita SK, Tsuno N, et al. Bcl-X(L) antisense sensitizes human colon cancer cell line to 5-fluorouracil [J]. Jpn J Cancer Res ,2000,91(8):825-832. 被引量:1
  • 10Broome HE, Yu AL, Diccianni M, et al. Inhibition of Bcl-XL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs[J]. Leuk Res, 2002,26(3):311-316. 被引量:1

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部